SCHEMBL25924599

SCHEMBL25924599

CC1CC(n2cnc3cc(Br)cc(CC(F)F)c32)C1

nearest known ligand 0.30

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 2/20 0.30
CYP2C9 P11712 1/20 0.30
KCNH2 Q12809 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25924607 0.77
SCHEMBL25924619 0.68 IDO1 (0.38) IDO1CYP2C9KCNH2
SCHEMBL25924494 0.65 IDO1 (0.37) IDO1CYP2C9KCNH2
SCHEMBL25318420 0.64 MAP3K12 (0.32)
SCHEMBL30506911 0.64 MAP3K12 (0.32)
SCHEMBL25924578 0.64 MAP3K12 (0.32)
SCHEMBL16428243 0.64 NQO2 (0.37)
SCHEMBL31349463 0.64 OPRM1 (0.31)
SCHEMBL25924927 0.62 PRPS1 (0.44) IDO1CYP2C9KCNH2
SCHEMBL17041972 0.62 ALDH1A1 (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023141432-A2 APOL1 INHIBITORS AND METHODS OF USE MAZE THERAPEUTICS, INC. (US) 2023-07-27 WO disclosed